	US 12,419,264 B2
	Modulating sugar and amino acid content in a plant (SULTR3)
Lucien Bovet, La Chaux-de-Fonds (CH)
Assigned to Philip Morris Products S.A., Neuchatel (CH)
Appl. No. 17/765,746
Filed by PHILIP MORRIS PRODUCTS S.A., Neuchatel (CH)
PCT Filed Sep. 28, 2020, PCT No. PCT/EP2020/077055 § 371(c)(1), (2) Date Mar. 31, 2022, PCT Pub. No. WO2021/063863, PCT Pub. Date Apr. 8, 2021.
Claims priority of application No. 19200856 (EP), filed on Oct. 1, 2019.
Prior Publication US 2023/0200344 A1, Jun. 29, 2023
Int. Cl. A01H 6/82 (2018.01); A24B 3/10 (2006.01); C12N 15/82 (2006.01)

CPC A01H 6/823 (2018.05) [A24B 3/10 (2013.01); C12N 15/8245 (2013.01); C12N 15/8251 (2013.01)]

19 Claims

1. A plant cell comprising:

(i) a polynucleotide comprising a sequence having at least 90 sequence identity to SEQ ID NO: 1 (NtSULTR3;1A-S) or SEQ ID NO: 3 (NtSULTR3;1A-T);

(ii) a polypeptide encoded by the polynucleotide set forth in (i);

(iii) a polypeptide comprising a sequence having at least 90% sequence identity to SEQ ID NO: 2 (NtSULTR3;1A-S) or at least 90% sequence identity to SEQ ID NO: 4 (NtSULTR3;1A-T); or

(iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i),

wherein said plant cell comprises at least one modification which reduces (a) the expression or activity of the polynucleotide or (b) the expression or activity of the polypeptide, as compared to a control plant cell in which the expression or activity of the polynucleotide or polypeptide has not been modified.